TALTZ
- Product NDC
- 0002-8900
- 11-digit product format
- 000028900
- Labeler code
- 0002
- Product ID
- 0002-8900_246fceb3-0f60-4bd7-8f06-4f34537f5d95
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ixekizumab
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Eli Lilly and Company
- Application
- BLA125521
- Marketing category
- BLA
- Marketing start
- 2016-03-22
- Substance
- IXEKIZUMAB
- Active strength
- 20 mg/.25mL
- Pharmacologic classes
- Interleukin-17A Antagonist [EPC], Interleukin-17A Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data
- Finished product
- Yes
- Brand name base
- TALTZ
- Listing expiration
- 2026-12-31
Active Ingredients
| Ingredient | Strength |
|---|
| IXEKIZUMAB | 20 mg/.25mL |
Harmonized Identifiers
| Field | Values |
|---|
| Unii | BTY153760O |
| Rxcui | 1745103, 1745108, 1745112, 1745114, 2674931, 2674932, 2674933, 2674934 |
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| BTY153760O | IXEKIZUMAB | 1143503-69-8 | IXEKIZUMAB |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 0002-8900-11 | 00002890011 | 1 SYRINGE in 1 CARTON (0002-8900-11) / 1 mL in 1 SYRINGE (0002-8900-01) | 1 syringe | 2024-02-02 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| TALTZ | Eli Lilly and Company | 2024-11-13 | HUMAN PRESCRIPTION DRUG LABEL | 39 |